Trade Filings
Managers Stocks Filings Superinvestors
Signals Institutional Buying Institutional Selling Insider Activity 13D & 13G Watch Sector Rotation
Tools Stock Screener Manager Screener Compare Managers Consensus Baskets All Research Tools Data API
Learn & AI Learn Ask the Data AI Agents
News ★ Saved
About About us Methodology Contact Disclaimer
Reader
DATA PLANS

Historical data downloads — coming with accounts.

API GATEWAY

Free read-only JSON access to the site's cached data.

Dark mode

🧭 Guided View
New to markets — prices, yields, YTD, market cap? We explain every term as you browse, in plain English. Same data, with the help built in.

⚡ Expert View
You already know the market. Just the data — clean, fast and compact, with no extra explanations. This is the default view.

Interface language
Security record · archived quarter

ABCL

AbCellera Biologics Inc. · Healthcare · Biotechnology

12.50 +17.8% mkt cap $3.82B quote delayed (FMP) · as of Aug 25 22:08 UTC — separate from filing data below

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024
15Tracked holders
+1Δ holders
44.56MShares held
$224.16MReported value
+1New positions
−1Exits
Rising Conviction score 55/100 4 quarters of rising tracked shares ●●●●○○ How these are computed → Explain this at the Research Desk →

Momentum inputs (comparable managers): holder breadth +7.1% · share flow -2.0% · net new positions 0.0%formula
Ownership fragmentation — more holders, smaller aggregate stake

All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025

Ownership over time
QuarterHoldersΔSharesReported valueNewExits
Q2 2026 55 +1 68.44M $534.80M +7 −6
Q1 2026 54 -3 75.99M $265.38M +4 −8
Q4 2025 57 -1 59.76M $204.38M +2 −2
Q3 2025 15 +1 44.56M $224.16M +1 −1
Q2 2025 12 +1 42.81M $146.85M +1
Q1 2025 10 +1 34.92M $77.87M +1
Q4 2024 9 0 29.72M $87.07M +1 −1
Q3 2024 8 -1 22.08M $57.42M −1
Q2 2024 9 34.65M $102.56M
Holder count
Who holds it · Q3 2025
#ManagerSharesΔ sharesValueTheir weightHeld
1 Capital World Investors 13.36M 0.0% $67.21M 0.0% Held 4 SEC ↗
2 Baillie Gifford 10.42M +0.6% $52.43M 0.0% ▲ Add 6 SEC ↗
3 Baillie Gifford 10.42M +0.6% $52.43M 0.0% ▲ Add 6 SEC ↗
4 Baillie Gifford 10.42M +0.6% $52.43M 0.0% ▲ Add 6 SEC ↗
5 Baillie Gifford 10.42M +0.6% $52.43M 0.0% ▲ Add 6 SEC ↗
6 Two Sigma Investments 5.18M +25.9% $26.03M 0.0% ▲ Add 6 SEC ↗
7 BlackRock (passive) 3.64M -1.1% $18.32M 0.0% ▼ Trim 2 SEC ↗
8 BlackRock (passive) 3.64M -1.1% $18.32M 0.0% ▼ Trim 2 SEC ↗
9 BlackRock (passive) 3.64M -1.1% $18.32M 0.0% ▼ Trim 2 SEC ↗
10 BlackRock (passive) 3.64M -1.1% $18.32M 0.0% ▼ Trim 2 SEC ↗
11 BlackRock (passive) 3.64M -1.1% $18.32M 0.0% ▼ Trim 2 SEC ↗
12 BlackRock (passive) 3.64M -1.1% $18.32M 0.0% ▼ Trim 2 SEC ↗
13 BlackRock (passive) 3.64M -1.1% $18.32M 0.0% ▼ Trim 2 SEC ↗
14 BlackRock (passive) 3.64M -1.1% $18.32M 0.0% ▼ Trim 2 SEC ↗
15 BlackRock (passive) 3.64M -1.1% $18.32M 0.0% ▼ Trim 2 SEC ↗
16 Renaissance Technologies 3.36M +1.6% $16.90M 0.0% ▲ Add 6 SEC ↗
17 Morgan Stanley 2.79M $14.04M 0.0% n/c 1 SEC ↗
18 Morgan Stanley 2.79M $14.04M 0.0% n/c 1 SEC ↗
19 Morgan Stanley 2.79M $14.04M 0.0% n/c 1 SEC ↗
20 Morgan Stanley 2.79M $14.04M 0.0% n/c 1 SEC ↗
21 Morgan Stanley 2.79M $14.04M 0.0% n/c 1 SEC ↗
22 Millennium Management 2.43M -28.5% $12.22M 0.0% ▼ Trim 6 SEC ↗
23 Citadel Advisors 1.01M -65.1% $5.07M 0.0% ▼ Trim 6 SEC ↗
24 Arrowstreet Capital 736.95K New $3.71M 0.0% New 1 SEC ↗
25 State Street Global Advisors (passive) 671.02K +9.2% $3.38M 0.0% ▲ Add 4 SEC ↗
26 Geode Capital Management (passive) 329.22K -9.3% $1.66M 0.0% ▼ Trim 6 SEC ↗
27 JPMorgan Chase 261.33K $1.31M 0.0% n/c 1 SEC ↗
28 JPMorgan Chase 261.33K $1.31M 0.0% n/c 1 SEC ↗
29 JPMorgan Chase 261.33K $1.31M 0.0% n/c 1 SEC ↗
30 JPMorgan Chase 261.33K $1.31M 0.0% n/c 1 SEC ↗
31 JPMorgan Chase 261.33K $1.31M 0.0% n/c 1 SEC ↗
32 JPMorgan Chase 261.33K $1.31M 0.0% n/c 1 SEC ↗
33 JPMorgan Chase 261.33K $1.31M 0.0% n/c 1 SEC ↗
34 JPMorgan Chase 261.33K $1.31M 0.0% n/c 1 SEC ↗
35 Goldman Sachs Group 250.22K $1.26M 0.0% n/c 1 SEC ↗
36 D. E. Shaw & Co. 76.48K +49.8% $384,709 0.0% ▲ Add 2 SEC ↗
37 Marshall Wace 47.48K 0.0% $238,824 0.0% Held 3 SEC ↗

“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.

New buyers

Arrowstreet Capital $3.71M 0.0%

Exited

Norges Bank $2.16M was 0.0%

Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 136 holders, 124.20M shares, $428.91M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.

Frequently co-owned

What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.

Insider transactions

Open-market purchases (P)

Aug 24 Hayden Michael R

Director · 53.61K sh @ 10.64 · $570,442

Aug 18 Montalbano John S.

Director · 10.00K sh @ 11.03 · $110,300

Aug 14 Booth Andrew

Officer · Chief Financial… · 37.20K sh @ 10.32 · $383,904

Aug 12 Hayden Michael R

Director · 46.39K sh @ 10.37 · $481,033

Open-market sales (S)

No open-market insider sales in our coverage window.

Awards, exercises and tax withholding are never counted as buys or sales here. Methodology

Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR. Reporting period: Q3 2025 · Methodology · Get this via the API